Drug · DIN 02563576
ELFABRIO
SINGLE-USE VIAL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since May 12, 2026; first marketed May 12, 2026.
- Drug Identification Number (DIN)
- 02563576
- Company (DIN owner)
- Chiesi Farmaceutici S.P.A.Parma, Italy
- Schedule
- Prescription; Schedule D
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Pegunigalsidase alfa A16AB20
- Class
- Human
- Record last updated
- August 7, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PEGUNIGALSIDASE ALFA | 20 MG | 10 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 9, 2025: NOC 36501New Drug Submission (NDS)
Other DINs named ELFABRIO
- DIN 02563568 · Marketed